Current treatment of atopic dermatitis

Sheilagh M. Maguiness, Lyn Guenther

Research output: Contribution to journalArticle

Abstract

Atopic dermatitis is a chronic inflammatory skin disease characterized by three main clinical features: pruritus, xerosis, and inflammation. Individuals with this condition are also prone to secondary skin infections. The British Working Party's criteria for atopic dermatitis can be used to make the diagnosis. Although atopic dermatitis typically begins in early childhood, it can persist throughout life. Its remitting and relapsing nature can make treatment difficult. Current treatment encompasses a wide range of topical and oral agents and phototherapy. Until recently, antihistamines and the liberal use of moisturizers were the standard treatment to control pruritus and xerosis, and topical corticosteroids were generally used to control inflammation. As more information about the immune basis of the disease becomes known, new immune-modulating topical therapies (such as tacrolimus and ascomycin derivatives) and systemic agents (such as cyclosporine) are being used to treat it, with promising results.

Original languageEnglish (US)
Pages (from-to)226-233
Number of pages8
JournalCanadian Journal of Allergy and Clinical Immunology
Volume6
Issue number6
StatePublished - Dec 1 2001

Fingerprint

Atopic Dermatitis
Pruritus
Inflammation
Phototherapy
Histamine Antagonists
Immune System Diseases
Tacrolimus
Therapeutics
Coinfection
Skin Diseases
Cyclosporine
Adrenal Cortex Hormones
Skin

Cite this

Current treatment of atopic dermatitis. / Maguiness, Sheilagh M.; Guenther, Lyn.

In: Canadian Journal of Allergy and Clinical Immunology, Vol. 6, No. 6, 01.12.2001, p. 226-233.

Research output: Contribution to journalArticle

@article{0092cc60c49e467fbf906cc233db9930,
title = "Current treatment of atopic dermatitis",
abstract = "Atopic dermatitis is a chronic inflammatory skin disease characterized by three main clinical features: pruritus, xerosis, and inflammation. Individuals with this condition are also prone to secondary skin infections. The British Working Party's criteria for atopic dermatitis can be used to make the diagnosis. Although atopic dermatitis typically begins in early childhood, it can persist throughout life. Its remitting and relapsing nature can make treatment difficult. Current treatment encompasses a wide range of topical and oral agents and phototherapy. Until recently, antihistamines and the liberal use of moisturizers were the standard treatment to control pruritus and xerosis, and topical corticosteroids were generally used to control inflammation. As more information about the immune basis of the disease becomes known, new immune-modulating topical therapies (such as tacrolimus and ascomycin derivatives) and systemic agents (such as cyclosporine) are being used to treat it, with promising results.",
author = "Maguiness, {Sheilagh M.} and Lyn Guenther",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "6",
pages = "226--233",
journal = "Canadian Journal of Allergy and Clinical Immunology",
issn = "1203-844X",
publisher = "Mediaconcept, Inc.",
number = "6",

}

TY - JOUR

T1 - Current treatment of atopic dermatitis

AU - Maguiness, Sheilagh M.

AU - Guenther, Lyn

PY - 2001/12/1

Y1 - 2001/12/1

N2 - Atopic dermatitis is a chronic inflammatory skin disease characterized by three main clinical features: pruritus, xerosis, and inflammation. Individuals with this condition are also prone to secondary skin infections. The British Working Party's criteria for atopic dermatitis can be used to make the diagnosis. Although atopic dermatitis typically begins in early childhood, it can persist throughout life. Its remitting and relapsing nature can make treatment difficult. Current treatment encompasses a wide range of topical and oral agents and phototherapy. Until recently, antihistamines and the liberal use of moisturizers were the standard treatment to control pruritus and xerosis, and topical corticosteroids were generally used to control inflammation. As more information about the immune basis of the disease becomes known, new immune-modulating topical therapies (such as tacrolimus and ascomycin derivatives) and systemic agents (such as cyclosporine) are being used to treat it, with promising results.

AB - Atopic dermatitis is a chronic inflammatory skin disease characterized by three main clinical features: pruritus, xerosis, and inflammation. Individuals with this condition are also prone to secondary skin infections. The British Working Party's criteria for atopic dermatitis can be used to make the diagnosis. Although atopic dermatitis typically begins in early childhood, it can persist throughout life. Its remitting and relapsing nature can make treatment difficult. Current treatment encompasses a wide range of topical and oral agents and phototherapy. Until recently, antihistamines and the liberal use of moisturizers were the standard treatment to control pruritus and xerosis, and topical corticosteroids were generally used to control inflammation. As more information about the immune basis of the disease becomes known, new immune-modulating topical therapies (such as tacrolimus and ascomycin derivatives) and systemic agents (such as cyclosporine) are being used to treat it, with promising results.

UR - http://www.scopus.com/inward/record.url?scp=0035700451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035700451&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 226

EP - 233

JO - Canadian Journal of Allergy and Clinical Immunology

JF - Canadian Journal of Allergy and Clinical Immunology

SN - 1203-844X

IS - 6

ER -